Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The pro-apoptotic BH3-only members of the Bcl2 family, crucial initiators of cell death, are activated by a diverse array of developmental cues or experimentally applied stress stimuli. We have investigated, through gene targeting in mice, the biological roles for the BH3-only family member HRK (also known as DP5) in apoptosis regulation. Hrk gene expression was found to be restricted to cells and tissues of the central and peripheral nervous systems. Sensory neurons from mice lacking Hrk were less sensitive to apoptosis induced by nerve growth factor (NGF) withdrawal, consistent with the induction of Hrk following NGF deprivation. By contrast, cerebellar granule neurons that upregulate Hrk upon transfer to low-K+ medium underwent apoptosis normally under these conditions in the absence of Hrk. Furthermore, loss of Hrk was not sufficient to rescue the neuronal degeneration in lurcher mutant mice. Despite previous reports, no evidence was found for Hrk expression or induction in growth-factor-dependent haematopoietic cell lines following withdrawal of their requisite cytokine, and haematopoietic progenitors lacking HRK died normally in response to cytokine deprivation. These results demonstrate that HRK contributes to apoptosis signalling elicited by trophic factor withdrawal in certain neuronal populations but is dispensable for apoptosis of haematopoietic cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795636PMC
http://dx.doi.org/10.1242/jcs.002063DOI Listing

Publication Analysis

Top Keywords

hrk
10
contributes apoptosis
8
neuronal populations
8
populations dispensable
8
haematopoietic cell
8
lacking hrk
8
apoptosis
7
hrk/dp5 contributes
4
apoptosis select
4
select neuronal
4

Similar Publications

Molecular mechanisms underlying HRK interaction with BCL-XL and BCL-2 reveal specificity determinants for BH3 mimetics.

iScience

September 2025

Department of Oncology, NHC Key Laboratory of Cancer Proteomics & State Local Joint Engineering Laboratory for Anticancer Drugs, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

BH3 mimetics targeting the BCL-2 family hold broad promise for cancer therapy. High similarity between the anti-apoptotic proteins BCL-XL and BCL-2 challenges the engineering of selective inhibitors. The BH3-only protein HRK is a natural selective inhibitor of BCL-XL and to a less extent of BCL-2.

View Article and Find Full Text PDF

Polyamines are regulatory metabolites with key roles in transcription, translation, cell signalling and autophagy. They are implicated in multiple neurological disorders, including stroke, epilepsy and neurodegeneration, and can regulate neuronal excitability through interactions with ion channels. Polyamines have been linked to pain, showing altered levels in human persistent pain states and modulation of pain behaviour in animal models.

View Article and Find Full Text PDF

Trained immunity presents a unique target for modulating the immune response against infectious and non-infectious threats to human health. To address the unmet need for training-targeted therapies, we explore bioengineering methods to answer research questions and address clinical applications. Current challenges in trained immunity include self-propagating autoinflammatory disease, a lack of controllable cell and tissue specificity, and the unintentional induction of training by known drugs and diseases.

View Article and Find Full Text PDF

Purpose: Regaining independence in gait is a major goal of stroke rehabilitation. Although gait ability is significantly affected by age and motor paresis, independent walking can be achieved even in patients with advanced age and/or severe paresis. Brain imaging provides valuable prognostic information regarding gait independence.

View Article and Find Full Text PDF

Tumour necrosis factor (TNF) plays a critical role in tumour progression, but the specific involvement of mRNA in this process, particularly in kidney renal clear cell carcinoma (KIRC) remains insufficiently understood. Our study aims to develop a TNF-related mRNA (TRmRNA) model to predict prognosis and inform treatment strategies in KIRC. KIRC expression data from The Cancer Genome Atlas (TCGA) and TNF-related genes (TRGs) from the Genecards database were used to construct and validate a TRmRNA prognostic model.

View Article and Find Full Text PDF